Advanced search
Publication Cover
Journal of Biomolecular Structure and Dynamics Volume 39, 2021 - Issue 9
Journal homepage
8,069
Views
124
CrossRef citations to date
0
Altmetric
Research Articles

Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants

Gideon A. GyebiDepartment of Biological Sciences, Salem University, Lokoja, Nigeria; Correspondence[email protected]
,
Olalekan B. OgunroDepartment of Biological Sciences, KolaDaisi University, Ibadan, Nigeria;
,
Adegbenro P. AdegunloyeDepartment of Biochemistry, Faculty of Life Sciences, University of Ilorin, Ilorin, Nigeria;
,
Oludare M. OgunyemiDepartment of Biological Sciences, Salem University, Lokoja, Nigeria;
&
Saheed O. AfolabiDepartment of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria
Pages 3396-3408 | Received 22 Apr 2020, Accepted 28 Apr 2020, Published online: 18 May 2020

Citations (124)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (34)

Gideon A. Gyebi, Oludare M. Ogunyemi, Adedotun A. Adefolalu, Juan F. López-Pastor, Antonio J. Banegas-Luna, Alejandro Rodríguez-Martínez, Horacio Pérez-Sánchez, Adegbenro P. Adegunloye, Olalekan B. Ogunro, Saheed O. Afolabi, Alaa Baazeem, Saqer S. Alotaibi & Gaber El-Saber Batiha. (2023) Antimalarial phytochemicals as potential inhibitors of SARS-CoV-2 guanine N7-methyltransferase (nsp 14): an integrated computational approach. Journal of Biomolecular Structure and Dynamics 41:11, pages 5022-5044.
Read now
Sreus A. G. Naidu, Yamini B. Tripathi, Priya Shree, Roger A. Clemens & A. Satyanarayan Naidu. (2023) Phytonutrient Inhibitors of SARS-CoV-2/NSP5-Encoded Main Protease (Mpro) Autocleavage Enzyme Critical for COVID-19 Pathogenesis. Journal of Dietary Supplements 20:2, pages 284-311.
Read now
Jurica Novak, Hrvoje Rimac, Shivananda Kandagalla, Prateek Pathak, Vladislav Naumovich, Maria Grishina & Vladimir Potemkin. (2022) Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking. Journal of Biomolecular Structure and Dynamics 40:19, pages 9347-9360.
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2022) Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using computational approaches. Journal of Biomolecular Structure and Dynamics 40:9, pages 4110-4121.
Read now
Ananta Swargiary, Shafi Mahmud & Md. Abu Saleh. (2022) Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19. Journal of Biomolecular Structure and Dynamics 40:5, pages 2067-2081.
Read now
Gideon A. Gyebi, Adegbenro P. Adegunloye, Ibrahim M. Ibrahim, Oludare M. Ogunyemi, Saheed O. Afolabi & Olalekan B. Ogunro. (2022) Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2. Journal of Biomolecular Structure and Dynamics 40:5, pages 2121-2145.
Read now
Janmejaya Rout, Bikash Chandra Swain & Umakanta Tripathy. (2022) In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:2, pages 860-874.
Read now
Aniket Sharma, Shubham Goyal, Arvind Kumar Yadav, Pawan Kumar & Lovely Gupta. (2022) In-silico screening of plant-derived antivirals against main protease, 3CLpro and endoribonuclease, NSP15 proteins of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:1, pages 86-100.
Read now
Vipul Kumar, Jaspreet Kaur Dhanjal, Priyanshu Bhargava, Ashish Kaul, Jia Wang, Huayue Zhang, Sunil C. Kaul, Renu Wadhwa & Durai Sundar. (2022) Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. Journal of Biomolecular Structure and Dynamics 40:1, pages 1-13.
Read now
Khedidja Benarous, Fatima Zohra Benali, Ikram Cherifa Bekhaoua & Mohamed Yousfi. (2021) Novel potent natural peroxidases inhibitors with in vitro assays, inhibition mechanism and molecular docking of phenolic compounds and alkaloids. Journal of Biomolecular Structure and Dynamics 39:18, pages 7168-7180.
Read now
Soumita Mukherjee, Subrata Dasgupta, Tapasendra Adhikary, Utpal Adhikari & Sujit Sankar Panja. (2021) Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study. Journal of Biomolecular Structure and Dynamics 39:18, pages 7322-7334.
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2021) Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics 39:17, pages 6747-6760.
Read now
Pradeep Sharma, Viswanathan Vijayan, Pradeep Pant, Mohita Sharma, Naval Vikram, Punit Kaur, T. P. Singh & Sujata Sharma. (2021) Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:17, pages 6649-6659.
Read now
Nima Razzaghi-Asl, Ahmad Ebadi, Sara Shahabipour & Danial Gholamin. (2021) Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Journal of Biomolecular Structure and Dynamics 39:17, pages 6633-6648.
Read now
Devashan Naidoo, Ayan Roy, Pallab Kar, Taurai Mutanda & Akash Anandraj. (2021) Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis. Journal of Biomolecular Structure and Dynamics 39:16, pages 6218-6230.
Read now
Toluwase Hezekiah Fatoki, Omodele Ibraheem, Ibukun Oladejo Ogunyemi, Afolabi Clement Akinmoladun, Harriet U. Ugboko, Catherine Joke Adeseko, Oladoja A. Awofisayo, Sunday Joseph Olusegun & Jesupemi Mercy Enibukun. (2021) Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants. Journal of Biomolecular Structure and Dynamics 39:16, pages 6195-6217.
Read now
Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne, Uddhavesh Sonavane, Asheet Kumar Nath, Hemant Darbari & Rajendra Joshi. (2021) Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro). Journal of Biomolecular Structure and Dynamics 39:15, pages 5735-5755.
Read now
Manish Kumar Tripathi, Pushpendra Singh, Sujata Sharma, Tej P. Singh, A. S. Ethayathulla & Punit Kaur. (2021) Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure and Dynamics 39:15, pages 5668-5681.
Read now
Abdullah G. Al-Sehemi, Mehboobali Pannipara, Rishikesh S. Parulekar, Omkar Patil, Prafulla B. Choudhari, M. S. Bhatia, P. K. Zubaidha & Yasinalli Tamboli. (2021) Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis. Journal of Biomolecular Structure and Dynamics 39:15, pages 5804-5818.
Read now
Santanu Sasidharan, Chandrabose Selvaraj, Sanjeev Kumar Singh, Vikash Kumar Dubey, Sachin Kumar, Arsenio M. Fialho & Prakash Saudagar. (2021) Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 39:15, pages 5706-5721.
Read now
Iruthayaraj Ancy, Mugudeeswaran Sivanandam & Poomani Kumaradhas. (2021) Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study. Journal of Biomolecular Structure and Dynamics 39:15, pages 5368-5375.
Read now
Hamidreza Khodajou-Masouleh, S. Shirin Shahangian & Behnam Rasti. (2021) Reinforcing our defense or weakening the enemy? A comparative overview of defensive and offensive strategies developed to confront COVID-19. Drug Metabolism Reviews 53:4, pages 508-541.
Read now
Pallab Kar, Neeta Raj Sharma, Bhupender Singh, Arnab Sen & Ayan Roy. (2021) Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. Journal of Biomolecular Structure and Dynamics 39:13, pages 4774-4785.
Read now
Sk. Abdul Amin, Kalyan Ghosh, Shovanlal Gayen & Tarun Jha. (2021) Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors. Journal of Biomolecular Structure and Dynamics 39:13, pages 4764-4773.
Read now
K. G. Arun, C. S Sharanya, J. Abhithaj, Dileep Francis & C. Sadasivan. (2021) Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. Journal of Biomolecular Structure and Dynamics 39:13, pages 4647-4658.
Read now
Selvaraj Alagu Lakshmi, Raja Mohamed Beema Shafreen, Arumugam Priya & Karutha Pandian Shunmugiah. (2021) Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach. Journal of Biomolecular Structure and Dynamics 39:13, pages 4594-4609.
Read now
Chandrabose Selvaraj, Dhurvas Chandrasekaran Dinesh, Umesh Panwar, Rajaram Abhirami, Evzen Boura & Sanjeev Kumar Singh. (2021) Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19. Journal of Biomolecular Structure and Dynamics 39:13, pages 4582-4593.
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2021) Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 39:12, pages 4362-4374.
Read now
Mark Tristan J. Quimque, Kin Israel R. Notarte, Rey Arturo T. Fernandez, Mark Andrew O. Mendoza, Rhenz Alfred D. Liman, Justin Allen K. Lim, Luis Agustin E. Pilapil, Jehiel Karsten H. Ong, Adriel M. Pastrana, Abbas Khan, Dong-Qing Wei & Allan Patrick G. Macabeo. (2021) Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics 39:12, pages 4316-4333.
Read now
Anshuman Chandra, Vaishali Gurjar, Imteyaz Qamar & Nagendra Singh. (2021) Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19. Journal of Biomolecular Structure and Dynamics 39:12, pages 4201-4211.
Read now
Muhammad Hamza, Ashaq Ali, Suliman Khan, Saeed Ahmed, Zarlish Attique, Saad Ur Rehman, Ayesha Khan, Hussain Ali, Muhammad Rizwan, Anum Munir, Arshad Mehmood Khan, Faiza Siddique, Azhar Mehmood, Faisal Nouroz & Sajid Khan. (2021) nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine. Journal of Biomolecular Structure and Dynamics 39:11, pages 4089-4099.
Read now
Vipul Kumar, Jaspreet Kaur Dhanjal, Sunil C. Kaul, Renu Wadhwa & Durai Sundar. (2021) Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. Journal of Biomolecular Structure and Dynamics 39:11, pages 3842-3854.
Read now
Satyajit Beura & Prabhakar Chetti. (2021) In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:10, pages 3747-3759.
Read now
Abdullahi Temitope Jamiu, Carolina H. Pohl, Sharafa Bello, Toluwase Adedoja & Saheed Sabiu. (2021) A review on molecular docking analysis of phytocompounds against SARS-CoV-2 druggable targets. All Life 14:1, pages 1100-1128.
Read now

Articles from other publishers (90)

Zahra Alipour, Somayeh Zarezadeh & Ali Akbar Ghotbi-Ravandi. (2023) The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review. Planta Medica.
Crossref
Doha H. Abou Baker, Emad M. Hassan & Souad El Gengaihi. (2023) An overview on medicinal plants used for combating coronavirus: Current potentials and challenges. Journal of Agriculture and Food Research 13, pages 100632.
Crossref
Olalekan Bukunmi Ogunro & Oluwaseun Ruth Olasehinde. 2023. Respiratory Insufficiency. Respiratory Insufficiency.
Mai Hussin Radi, Riham A. El-Shiekh, Ali M. El-Halawany & Essam Abdel-Sattar. (2023) Friedelin and 3β-Friedelinol: Pharmacological Activities. Revista Brasileira de Farmacognosia 33:5, pages 886-900.
Crossref
OLEG V. TINKOV, VENIAMIN YU. GRIGOREV & LYUDMILA D. GRIGOREVA. (2023) QSAR ANALYSIS OF HDAC6 INHIBITORS. Lomonosov chemistry journal 64:№1, 2023, pages 35-48.
Crossref
Susankar Kushari, Iswar Hazarika, Damiki Laloo, Suman Kumar, Jun Moni Kalita & Himangshu Sarma. (2022) An integrated computational approach towards the screening of active plant metabolites as potential inhibitors of SARS-CoV-2: an overview. Structural Chemistry 34:3, pages 1073-1104.
Crossref
Monica Dinodia. (2023) Microwave-promoted Synthesis of Novel Bioactive N-based Heterocycles. Mini-Reviews in Organic Chemistry 20:2, pages 136-155.
Crossref
Damodaran Sruthi, Menamadathil Dhanalakshmi, Hoovinakola Chinnappa Yashavantha Rao, Ramalingam Parthasarathy, Shashikala Paranthaman Deepanraj & Chelliah Jayabaskaran. (2023) Curative Potential of High-Value Phytochemicals on COVID-19 Infection. Biochemistry (Moscow) 88:1, pages 64-72.
Crossref
Abdirahman Elmi, Ahmed Said Mohamed, Saredo Said & Remy Bationo. 2023. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products 549 573 .
O. V. Tinkov, V. Yu. Grigorev & L. D. Grigoreva. (2023) QSAR Analysis of HDAC6 Inhibitors. Moscow University Chemistry Bulletin 77:S1, pages S25-S35.
Crossref
José Ednésio da Cruz Freire, José Edvar Monteiro Júnior, Daniel Pascoalino Pinheiro, Grayce Ellen da Cruz Paiva Lima, Camila Lopes do Amaral, Victor Rezende Veras, Mayara Ponte Madeira, Erika Bastos Lima Freire, Renan Galvão Ozório, Virgínia Oliveira Fernandes, Ana Paula Dias Rangel Montenegro, Raquel Carvalho Montenegro, Jeová Keny Baima Colares & Renan Magalhães Montenegro Júnior. (2022) Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics. 3 Biotech 12:12.
Crossref
Jorge Nochebuena & G. Andrés Cisneros. (2022) Polarizable MD and QM/MM investigation of acrylamide-based leads to target the main protease of SARS-CoV-2. The Journal of Chemical Physics 157:18.
Crossref
Aynaz Nourani, Vahid Rahimkhoei & Ali Akbari. (2022) Potential therapeutic drug candidates against SARS-CoV-2 (COVID‐19) through molecular docking: A review. Health Science Monitor 1:2, pages 89-106.
Crossref
Esley S. Santos, Priscila C. Silva, Paulo S.A. Sousa, Cristhyane C. Aquino, Gabriella Pacheco, Luiz F.L.S. Teixeira, Alyne R. Araujo, Francisca B.M. Sousa, Romulo O. Barros, Ricardo M. Ramos, Jefferson A. Rocha, Lucas A.D. Nicolau & Jand V.R. Medeiros. (2022) Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches. Chemico-Biological Interactions 367, pages 110161.
Crossref
Srividhya Venkataraman. (2022) Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses. Vaccines 10:11, pages 1805.
Crossref
Jehoshaphat Oppong Mensah, Gilbert Boadu Ampomah, Edward Ntim Gasu, Abigail Kusiwaa Adomako, Elliott Sarpong Menkah & Lawrence Sheringham Borquaye. (2022) Allosteric Modulation of the Main Protease (MPro) of SARS-CoV-2 by Casticin—Insights from Molecular Dynamics Simulations. Chemistry Africa 5:5, pages 1305-1320.
Crossref
Oluwatosin Temilade Adu, Farzana Mohamed, Yougasphree Naidoo, Temitope Samson Adu, Hafizah Chenia, Yaser Hassan Dewir & Hail Rihan. (2022) Green Synthesis of Silver Nanoparticles from Diospyros villosa Extracts and Evaluation of Antioxidant, Antimicrobial and Anti-Quorum Sensing Potential. Plants 11:19, pages 2514.
Crossref
Chattarin Ruchawapol, Wen-Wei Fu & Hong-Xi Xu. (2022) A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19. Phytomedicine 104, pages 154324.
Crossref
Francisco J. R. Mejías, Alexandra G. Durán, Nuria Chinchilla, Rosa M. Varela, José A. Álvarez, José M. G. Molinillo, Francisco García-Cozar & Francisco A. Macías. (2022) In Silico Evaluation of Sesquiterpenes and Benzoxazinoids Phytotoxins against Mpro, RNA Replicase and Spike Protein of SARS-CoV-2 by Molecular Dynamics. Inspired by Nature. Toxins 14:9, pages 599.
Crossref
Gideon A. Gyebi, Oludare M. Ogunyemi, Adedotun A. Adefolalu, Alejandro Rodríguez-Martínez, Juan F. López-Pastor, Antonio J. Banegas-Luna, Horacio Pérez-Sánchez, Adegbenro P. Adegunloye, Olalekan B. Ogunro & Saheed O. Afolabi. (2022) African derived phytocompounds may interfere with SARS-CoV-2 RNA capping machinery via inhibition of 2′-O-ribose methyltransferase: An in silico perspective. Journal of Molecular Structure 1262, pages 133019.
Crossref
Isha Rani, Avjit Kalsi, Gagandeep Kaur, Pankaj Sharma, Sumeet Gupta, Rupesh K. Gautam, Hitesh Chopra, Shabana Bibi, Syed Umair Ahmad, Inderbir Singh, Manish Dhawan & Talha Bin Emran. (2022) Modern drug discovery applications for the identification of novel candidates for COVID-19 infections. Annals of Medicine and Surgery 80, pages 104125.
Crossref
Hai-Long Zhang, Liya Ge, Yong-Xia Li & Ai-Feng Zhou. (2022) Recent Trends of Therapeutic Strategies against COVID-19. The Open COVID Journal 2:1.
Crossref
Rania Hamdy, Ahmed Mostafa, Noura M. Abo Shama, Sameh S. M. Soliman & Bahgat Fayed. (2022) Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS‐CoV‐2. Phytotherapy Research 36:7, pages 2921-2939.
Crossref
Bárbara Longhini Gonzalez, Natalia Castelhano de Oliveira, Mariane Roberta Ritter, Fernanda Stumpf Tonin, Eduardo Borges Melo, Andréia Cristina Conegero Sanches, Fernando Fernandez‐Llimos, Marcus Vinícius Petruco, João Carlos Palazzo de Mello, Danielly Chierrito & Daniela Cristina de Medeiros Araújo. (2022) The naturally‐derived alkaloids as a potential treatment for COVID ‐19: A scoping review . Phytotherapy Research 36:7, pages 2686-2709.
Crossref
Mehtap Kilic & Bilge Sener. 2022. Natural Drugs from Plants. Natural Drugs from Plants.
Farak Ali, Shahnaz Alom, Anshul Shakya, Surajit K. Ghosh, Udaya P. Singh & Hans R. Bhat. (2022) Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2. Archiv der Pharmazie 355:5.
Crossref
Hai-Long Zhang, Yong-Xia Li, Ai-Feng Zhou & Yiqian Li. (2022) New Frontier in Antiviral Drugs for Disorders of the Respiratory System. Recent Advances in Anti-Infective Drug Discovery 17:1, pages 2-12.
Crossref
Olabisi O. Ogunrinola, Rahmon I. Kanmodi & Oluwaseyi A. Ogunrinola. (2021) Medicinal plants as immune booster in the palliative management of viral diseases: A perspective on coronavirus. Food Frontiers 3:1, pages 83-95.
Crossref
Parastou Farshi, Eda Ceren Kaya, Fataneh Hashempour-Baltork & Kianoush Khosravi-Drani. (2022) The Effect of Plant Metabolites on Coronaviruses: A Comprehensive Review Focusing on their IC50 Values and Molecular Docking Scores. Mini-Reviews in Medicinal Chemistry 22:3, pages 457-483.
Crossref
Md. Junaid, Yeasmin Akter, Aysha Siddika, S. M. Abdul Nayeem, Afsana Nahrin, Syeda Samira Afrose, Md. Muzahid Ahmed Ezaj & Muhammad Shaiful Alam. (2022) Nature-Derived Hit, Lead, and Drug-Like Small Molecules: Current Status and Future Aspects Against Key Target Proteins of Coronaviruses. Mini-Reviews in Medicinal Chemistry 22:3, pages 498-549.
Crossref
Zhi-Gang Sun, Feng-Ling Yu, Xiang-Ting Qiu, Shuang Li, Xue-Tang Li & Hai-Liang Zhu. (2022) Promising Enzymes for Inhibitors Development Against COVID-19. Mini-Reviews in Medicinal Chemistry 22:3, pages 449-456.
Crossref
Nouhoum Bouare, Daouda Kassim Minta, Abdoulaye Dabo & Christiane Gerard. (2022) COVID-19: A pluralistic and integrated approach for efficient management of the pandemic. World Journal of Virology 11:1, pages 20-39.
Crossref
Cecilia Salugta Cordero, Ulrich Meve & Grecebio Jonathan Duran Alejandro. (2022) Ethnobotanical Documentation of Medicinal Plants Used by the Indigenous Panay Bukidnon in Lambunao, Iloilo, Philippines. Frontiers in Pharmacology 12.
Crossref
Farnoosh Kazemi, Mahdi Mojarrab, Gholamreza Bahrami, SeyedShahram Miraghaei, Saba Hadidi & MohammadBagher Majnooni. (2022) The alkaloids of Isatis indigotica as promising candidates against COVID-19: A molecular docking simulation for drug development. Journal of Reports in Pharmaceutical Sciences 11:2, pages 165.
Crossref
Denisse de Loera. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19 339 385 .
Aboyeji Lukuman Oyewole, Abdulmusawwir O. Alli-Oluwafuyi, Abdulrazaq Bidemi Nafiu & Aminu Imam. 2022. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics 329 350 .
Raghvendra Dubey & Kushagra Dubey. 2022. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention 203 244 .
Jun Zhao, Qinhai Ma, Baoyue Zhang, Pengfei Guo, Zhe Wang, Yi Liu, Minsi Meng, Ailin Liu, Zifeng Yang & Guanhua Du. (2021) Exploration of SARS-CoV-2 3CL pro Inhibitors by Virtual Screening Methods, FRET Detection, and CPE Assay . Journal of Chemical Information and Modeling 61:12, pages 5763-5773.
Crossref
Tamirat Bekele Beressa, Serawit Deyno, Andrew G. Mtewa, Namuli Aidah, Naasson Tuyiringire, Ben Lukubye, Anke Weisheit, Casim Umba Tolo & Patrick Engeu Ogwang. (2021) Potential Benefits of Antiviral African Medicinal Plants in the Management of Viral Infections: Systematic Review. Frontiers in Pharmacology 12.
Crossref
Gideon A. Gyebi, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, Olalekan B. Ogunro, Adegbenro P. Adegunloye & Saheed O. Afolabi. (2021) SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids. Journal of Genetic Engineering and Biotechnology 19:1.
Crossref
Olutayo Ademola Adeleye, Mbang Nyong Femi-Oyewo, Oluyemisi Adebowale Bamiro, Lateef Gbenga Bakre, Akinyinka Alabi, Joseph Senu Ashidi, Olalekan Adeyinka Balogun-Agbaje, Oluwakemi Mary Hassan & Gbemisola Fakoya. (2021) Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Le-le Ma, Hui-min Liu, Xue-mei Liu, Xiao-yu Yuan, Chao Xu, Fang Wang, Jun-zhi Lin, Run-chun Xu & Ding-kun Zhang. (2021) Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19. European Journal of Medicinal Chemistry 226, pages 113857.
Crossref
Rafida Razali, Haslina Asis & Cahyo Budiman. (2021) Structure-Function Characteristics of SARS-CoV-2 Proteases and Their Potential Inhibitors from Microbial Sources. Microorganisms 9:12, pages 2481.
Crossref
Oludare M. Ogunyemi, Gideon A. Gyebi, Ibrahim M. Ibrahim, Charles O. Olaiya, Joshua O. Ocheje, Modupe M. Fabusiwa & Joseph O. Adebayo. (2021) Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening. RSC Advances 11:53, pages 33380-33398.
Crossref
Chun‐Chi Chen, Xuejing Yu, Chih‐Jung Kuo, Jian Min, Sizhuo Chen, Lixin Ma, Ke Liu & Rey‐Ting Guo. (2021) Overview of antiviral drug candidates targeting coronaviral 3C‐like main proteases. The FEBS Journal 288:17, pages 5089-5121.
Crossref
Gideon A. Gyebi, Abdo A. Elfiky, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, Adegbenro P. Adegunloye, Joseph O. Adebayo, Charles O. Olaiya, Joshua O. Ocheje & Modupe M. Fabusiwa. (2021) Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum. Computers in Biology and Medicine 136, pages 104671.
Crossref
M. El-Darier Salama, A. Rashed Suzan, Fayez Ayat, S. Hassanein Sarah, R. Sharaby Muhammed, M. Tawfik Noran, Mansour Heba & Adel Mohamed. (2021) Medicinal plant-derived compounds as potential phytotherapy forCOVID-19: Future perspectives. Journal of Pharmacognosy and Phytotherapy 13:3, pages 68-81.
Crossref
Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Darius Riziki Martin, Ashwil Klein, Abram Madiehe & Mervin Meyer. (2021) Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease. International Journal of Molecular Sciences 22:17, pages 9431.
Crossref
Gideon A. Gyebi, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, Saheed O. Afolabi & Joseph O. Adebayo. (2021) Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective. Computers in Biology and Medicine 134, pages 104406.
Crossref
Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi & Zahra Najafimemar. (2021) Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery. Future Virology 16:6, pages 389-397.
Crossref
Gaurav Joshi, Jayant Sindhu, Shikha Thakur, Abhilash Rana, Geetika Sharma, Mayank & Ramarao Poduri. (2021) Recent efforts for drug identification from phytochemicals against SARS-CoV-2: Exploration of the chemical space to identify druggable leads. Food and Chemical Toxicology 152, pages 112160.
Crossref
Ruikun Du, Laura Cooper, Zinuo Chen, Hyun Lee, Lijun Rong & Qinghua Cui. (2021) Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro. Antiviral Research 190, pages 105075.
Crossref
Mohammad Bagher Majnooni, Sajad Fakhri, Gholamreza Bahrami, Maryam Naseri, Mohammad Hosein Farzaei & Javier Echeverría. (2021) Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-21.
Crossref
Rachana Singh, Pradhyumna Kumar Singh, Rajnish Kumar, Md. Tanvir Kabir, Mohammad Amjad Kamal, Abdur Rauf, Ghadeer M. Albadrani, Amany A. Sayed, Shaker A. Mousa, Mohamed M. Abdel-Daim & Md. Sahab Uddin. (2021) Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19. Frontiers in Pharmacology 12.
Crossref
Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, Dhritiman Dey, Priyanka Sharma, Ravichandiran Velayutham, Syamal Roy & Dipanjan Ghosh. (2021) A review on potential of natural products in the management of COVID-19. RSC Advances 11:27, pages 16711-16735.
Crossref
Onder Otlu, Ceyhun Bereketoglu, Tugba Raika Kiran & Aysun Bay Karabulut. (2021) Medicinal Plants for Prevention and Treatment of Coronavirus Disease. Journal of Intelligent Systems with Applications, pages 74-85.
Crossref
Johnson Olaleye Oladele, Oyedotun Moses Oyeleke, Oluwaseun Titilope Oladele & Adenike Temidayo Oladiji. (2021) Covid-19 treatment: Investigation on the phytochemical constituents of Vernonia amygdalina as potential Coronavirus-2 inhibitors. Computational Toxicology 18, pages 100161.
Crossref
Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba & Chinedum Peace Babalola. (2021) Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective. Frontiers in Pharmacology 12.
Crossref
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2021) Identification of alkaloids from Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective. Journal of Molecular Structure 1229, pages 129489.
Crossref
Shah A. Khan & K. Al-Balushi. (2021) Combating COVID-19: The role of drug repurposing and medicinal plants. Journal of Infection and Public Health 14:4, pages 495-503.
Crossref
Serena Dotolo, Anna Marabotti, Angelo Facchiano & Roberto Tagliaferri. (2021) A review on drug repurposing applicable to COVID-19. Briefings in Bioinformatics 22:2, pages 726-741.
Crossref
Fatih M. Uckun, Saran Saund, Hitesh Windlass & Vuong Trieu. (2021) Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug. Frontiers in Pharmacology 12.
Crossref
Anirban Mandal, Ajeet Kumar Jha & Banasri Hazra. (2021) Plant Products as Inhibitors of Coronavirus 3CL Protease. Frontiers in Pharmacology 12.
Crossref
Vladimir B. Sulimov, Danil C. Kutov, Anna S. Taschilova, Ivan S. Ilin, Eugene E. Tyrtyshnikov & Alexey V. Sulimov. (2021) Docking Paradigm in Drug Design. Current Topics in Medicinal Chemistry 21:6, pages 507-546.
Crossref
Shanmugaraj Gowrishankar, Sankar Muthumanickam, Arumugam Kamaladevi, Chandrasekar Karthika, Ravi Jothi, Pandi Boomi, Dharuman Maniazhagu & Shunmugiah Karutha Pandian. (2021) Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 – An in silico study. Food and Chemical Toxicology 148, pages 111966.
Crossref
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, Sajjad Ahmad & Guanglin Li. (2021) Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2. Molecules 26:3, pages 674.
Crossref
Isabella Romeo, Francesco Mesiti, Antonio Lupia & Stefano Alcaro. (2021) Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets. Molecules 26:3, pages 632.
Crossref
Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, Michael N. Alexis & Alexios-Leandros Skaltsounis. (2021) Natural and Nature-Derived Products Targeting Human Coronaviruses. Molecules 26:2, pages 448.
Crossref
Kalyan Ghosh, Sk. Abdul Amin, Shovanlal Gayen & Tarun Jha. (2021) Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors. Journal of Molecular Structure 1224, pages 129026.
Crossref
Didi Nurhadi Illian, Etti Sartina Siregar, Sumaiyah Sumaiyah, Ahmad Rusdan Utomo, Arif Nuryawan & Mohammad Basyuni. (2021) Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets. Heliyon 7:1, pages e06001.
Crossref
Chaima Mouffouk, Soumia Mouffouk, Sara Mouffouk, Leila Hambaba & Hamada Haba. (2021) Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2). European Journal of Pharmacology 891, pages 173759.
Crossref
Devvret Verma, Debasis Mitra, Manish Paul, Priya Chaudhary, Anshul Kamboj, Hrudayanath Thatoi, Pracheta Janmeda, Divya Jain, Periyasamy Panneerselvam, Rakesh Shrivastav, Kumud Pant & Pradeep K. Das Mohapatra. (2021) Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/ 3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components. Current Research in Pharmacology and Drug Discovery 2, pages 100038.
Crossref
Sk. Abdul Amin, Suvankar Banerjee, Kalyan Ghosh, Shovanlal Gayen & Tarun Jha. (2021) Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors. Bioorganic & Medicinal Chemistry 29, pages 115860.
Crossref
Devasena T.Devasena T.. 2021. Nanotechnology-COVID-19 Interface. Nanotechnology-COVID-19 Interface 71 114 .
Ekampreet Singh, Rameez Jabeer Khan, Rajat Kumar Jha, Gizachew Muluneh Amera, Monika Jain, Rashmi Prabha Singh, Jayaraman Muthukumaran & Amit Kumar Singh. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses 135 162 .
Ekampreet Singh, Rameez Jabeer Khan, Rajat Kumar Jha, Gizachew Muluneh Amera, Monika Jain, Rashmi Prabha Singh, Jayaraman Muthukumaran & Amit Kumar Singh. (2020) A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods. Journal of Genetic Engineering and Biotechnology 18:1.
Crossref
Ambrish Saxena. (2020) Drug targets for COVID-19 therapeutics: Ongoing global efforts. Journal of Biosciences 45:1.
Crossref
Pratap Kumar Parida, Dipak Paul & Debamitra Chakravorty. (2020) The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS‐CoV ‐2 targets . Phytotherapy Research 34:12, pages 3420-3433.
Crossref
Mohammad Bagher Majnooni, Sajad Fakhri, Yalda Shokoohinia, Narges Kiyani, Katrina Stage, Pantea Mohammadi, Mohammad Mehdi Gravandi, Mohammad Hosein Farzaei & Javier Echeverría. (2020) Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury. Frontiers in Pharmacology 11.
Crossref
Meenakshi Negi, Pooja A. Chawla, Abdul Faruk & Viney Chawla. (2020) Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic. Bioorganic Chemistry 104, pages 104315.
Crossref
Junqing Huang, Gabriel Tao, Jingwen Liu, Junming Cai, Zhongyu Huang & Jia-xu Chen. (2020) Current Prevention of COVID-19: Natural Products and Herbal Medicine. Frontiers in Pharmacology 11.
Crossref
Anna-Gaelle Giguet-Valard, Kevin Raguette, Stephanie Morin, Remi Bellance & Juliette Smith Ravin. (2020) Gossypetin Derivatives are also Putative Inhibitors of SARS-COV 2: Results of a Computational Study. Journal of Biomedical Research & Environmental Sciences 1:6, pages 201-212.
Crossref
Andres F. Yepes-Pérez, Oscar Herrera-Calderon, José-Emilio Sánchez-Aparicio, Laura Tiessler-Sala, Jean-Didier Maréchal & Wilson Cardona-G. (2020) Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat’s Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-14.
Crossref
Lawrence Sheringham Borquaye, Edward Ntim Gasu, Gilbert Boadu Ampomah, Lois Kwane Kyei, Margaret Amerley Amarh, Caleb Nketia Mensah, Daniel Nartey, Michael Commodore, Abigail Kusiwaa Adomako, Philipina Acheampong, Jehoshaphat Oppong Mensah, David Batsa Mormor & Caleb Impraim Aboagye. (2020) Alkaloids from Cryptolepis sanguinolenta as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study . BioMed Research International 2020, pages 1-14.
Crossref
Franklyn Nonso Iheagwam & Solomon Oladapo Rotimi. (2020) Computer-Aided Analysis of Multiple SARS-CoV-2 Therapeutic Targets: Identification of Potent Molecules from African Medicinal Plants. Scientifica 2020, pages 1-25.
Crossref
Johnson O. Oladele, Ebenezer I. Ajayi, Oyedotun M. Oyeleke, Oluwaseun T. Oladele, Boyede D. Olowookere, Boluwaji M. Adeniyi, Olu I. Oyewole & Adenike T. Oladiji. (2020) A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants. Heliyon 6:9, pages e04897.
Crossref
Farhana Rumzum Bhuiyan, Sabbir Howlader, Topu Raihan & Mahmudul Hasan. (2020) Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic. Frontiers in Medicine 7.
Crossref
Phaedra Eleftheriou, Dionysia Amanatidou, Anthi Petrou & Athina Geronikaki. (2020) In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Molecules 25:11, pages 2529.
Crossref
Oludare M Ogunyemi, Gideon A Gyebi, Abdo A Elfiky, Saheed O Afolabi, Olalekan B Ogunro, Adegbenro P Adegunloye & Ibrahim M Ibrahim. (2020) Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective . Antiviral Chemistry and Chemotherapy 28, pages 204020662098407.
Crossref
Nilanjan Adhikari, Sk. Abdul Amin & Tarun Jha. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses 329 431 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.